|
SMC4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.244000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.738840E-01 |
| Normal-vs-Stage2 |
4.879000E-01 |
| Normal-vs-Stage3 |
9.328400E-01 |
| Normal-vs-Stage4 |
2.807600E-02 |
| Stage1-vs-Stage2 |
7.240100E-02 |
| Stage1-vs-Stage3 |
6.388500E-02 |
| Stage1-vs-Stage4 |
1.382770E-01 |
| Stage2-vs-Stage3 |
5.012000E-01 |
| Stage2-vs-Stage4 |
1.476120E-02 |
| Stage3-vs-Stage4 |
1.702320E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.235000E-01 |
| Normal-vs-AfricanAmerican |
4.326200E-01 |
| Normal-vs-Asian |
8.282300E-02 |
| Caucasian-vs-AfricanAmerican |
9.753200E-01 |
| Caucasian-vs-Asian |
2.916400E-01 |
| AfricanAmerican-vs-Asian |
4.694800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.113200E-01 |
| Normal-vs-Female |
3.176200E-01 |
| Male-vs-Female |
8.411600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.578400E-02 |
| Normal-vs-Age(41-60Yrs) |
7.344600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.713400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.073820E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.224780E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.980000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.811200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.361780E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.557700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.448200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.284600E-01 |
| Classical-VS-Follicular |
2.02259999999566E-05 |
| Classical-VS-Other |
7.146500E-02 |
| Classical-VS-Normal |
5.081600E-02 |
| Tall-VS-Follicular |
1.459950E-02 |
| Tall-VS-Other |
6.076200E-02 |
| Tall-VS-Normal |
1.615620E-01 |
| Follicular-VS-Other |
7.271000E-01 |
| Follicular-VS-Normal |
1.722040E-01 |
| Other-VS-Normal |
2.602400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.798000E-01 |
| Normal-vs-N1 |
5.194100E-02 |
| N0-vs-N1 |
1.852440E-02 |
|
|
